Successful Use of Bortezomib-Lenalidomide Combination as Treatment for a Patient With Plasmablastic Lymphoma.

Successful Use of Bortezomib-Lenalidomide Combination as Treatment for a Patient With Plasmablastic Lymphoma. Clin Lymphoma Myeloma Leuk. 2018 May 04;: Authors: Marrero WD, Cruz-Chacón A, Castillo C, Cabanillas F PMID: 29753690 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29753690?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - May 4, 2018 Category: Cancer & Oncology Authors: Marrero WD, Cruz-Chacón A, Castillo C, Cabanillas F Tags: Clin Lymphoma Myeloma Leuk Source Type: research

More News: Cancer & Oncology | Lymphoma | Myeloma | Revlimid | Velcade